Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about LSD Therapy

Recent news which mentions LSD Therapy

Can LSD Therapy Calm Anxious Dogs? First-Of-Its-Kind Study Uncovers New Possibilities
Tickers DOGS PETS
Tags pets LSD veterinary
From Benzinga
Podcast: LSD 'Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics' Says MindMed's R. Barrow
Tickers MNMD NEWS
Tags MNMD Management Legal
From Benzinga
MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds
Tickers MNMD NEWS
Tags News MNMD Management
From Benzinga
MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials
Tickers CMPS MNMD NEWS
Tags Biotech Breakthrough Therapy Drug Generalized Anxiety Disorder
From Benzinga
MindMed's 2023 Financial Results And Business Recap: Milestones Amid Rising Expenses
Tickers MNMD
Tags MNMD Management LSD Therapy
From Benzinga
MindMed's 2024 Plans: Anxiety Treatment Stands, LSD Microdosing For ADHD Will Be Discontinued
Tickers MNMD NEWS
Tags Penny Stocks Psychedelic/Assisted Therapies Benzinga
From Benzinga
Federico Fellini's LSD Journey: How It Inspired Some Of The Greatest Films Of All Time
Tags Psychedelics Cannabis LSD Therapy
From Benzinga
BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives
Tickers BETRF PHRRF
Tags Benzinga FDA Psychedelic/Assisted Therapies
From Benzinga
Numinus' Clinical Arm To Lead Enrollment Site For MindMed's Phase 2b LSD Study
Tickers CMPS MNMD NUMIF
Tags Psychedelic/Assisted Therapies Penny Stocks NUMIF
From Benzinga
MindMed And FCM Holdings' Dispute Over Clinical Path Forward Deepens
Tickers MNMD
Tags MNMD Proxy fight News
From Benzinga
MindMed's LSD Study For Anxiety Treatment Enrolls And Doses 100 Participants, More Expected
Tickers MNMD
Tags News Management MNMD
From Benzinga
MindMed Reports Q1 2023 Financial Results, Business Highlights, Upcoming Elections
Tickers MNMD
Tags Market News Guidance Cannabis
From Benzinga
80 Years Post-Discovery, LSD Shows Significant Potential For Major Depression In Advanced Clinical Trial
Tickers MNMD
Tags Guidance Top Stories Markets
From Benzinga
LSD's Impact On The Body's Cannabinoid And Microorganisms Systems, New Study Sheds Light
Tags endocannabinoid system British Journal of Pharmacology Psychedelics
From Benzinga
Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More
Tickers AWKNF CMND CMPS PSIL
Tags Benzinga Psychedelic/Assisted Therapies Penny Stocks
From Benzinga
MindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 Trials
Tickers MNMD
Tags Psychedelics LSD Therapy Cannabis
From Benzinga
LSD Microdosing Yields Positive Outcomes In Phase 1 Study, More Trials On Depression & Existential Distress
Tickers BLRZF
Tags Markets News Penny Stocks
From Benzinga
Psychedelics Companies And IPs: An Extended Patent Application To Protect Multiple LSD Derivatives
Tickers BETRF
Tags Psychedelics Non/Hallucinogenic Psychedelic Compound Benzinga
From Benzinga
This LSD Phase 2 Clinical Trial Is Showing Positive Results For Treatment Of Generalized Anxiety
Tickers MNMD
Tags Biological Psychiatry Benzinga Cannabis
From Benzinga
Connecting To Nature Through Psychedelics
Tickers TECH
Tags Psychedelics Market News Nature
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.